When a fast particle passes through tissue, there is a certain probability that a nuclear interaction will occur with a nucleus of the . medium, and that the product nucleus will be radioactive. Tissue activation was first discussed by Tobias (1947) and Tobias and Dunn (19 4 9).
Nuclear reactions initiated by positively charged particles often leave a nucleus which has too many protons for stability, and.therefore tendsto decay by positron emission. Examples of such reactions include (p, y), (p,d) , (p,n) , (p,2n) , (d,n) , (d,t) , (QI,n) , (QI, 2n) , and (QI,QIU). Charged particle activation has been reviewed by Tilbury and Wahl (1965) and Tilbury (1966) . Since many such activation reactions are endoergic, the incoming particle must have ilOt only enough kinetic energy to penetrate the Goulomb barrier (2 to 5 MeV in light elements), but also enough to meet the Q-value for the reaction. For ;:tlpha particles of energy greater than 25 MeV, total cross sections for such reactions in carbon, nitrogen, and oxygen may be as large as 500 mb. Thus when: an energetic.
alpha particle beam passes through tissue, .as in medical irradiation, it leaves behind a weak trail of radioactive nuclei, mostly ~hort-lived positron and y:"ray emitters.
Some of the important alpha particle activation reactions in tis sue are shown in Table 1 , along with the modes of decay of the radioactive product nuclei. The maximum energy of the emitted particle spectrum is given above the arrow, and the decay half-life ~s given below the arrow.
Data are taken fro111. Lederer, Hollander, and Perlman (1967) .
The most important characteristic of the positron decay proces s, for our purposes, is the fact that when the positron reaches the end of sirn.ultaneous detection of the y':'ray pair. This is the basis of the activation studies to be discussed'in the following sections. The energy dependence of the cross section is plotted in fig. 3 .
The cross section rises steeply from the threshold at 22 MeV, and is relatively constant at around 50 mb over a wide energy range up to 380
MeV. This behaviour is typical of many Charged-particle activation reactions, that is, rising quickly from a threshold to a broad plateau and then gradually falling off due to competition f~om other reactions. Thus
the activation behaviour of a charged monoenergetic heavy particle beam
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in matter' is likely to be a relatively uniform distribution along the track.
which drops abruptly to nothing when the residual range of 'the particles decreases to that c~rresponding to the threshold energy of the reaction.
In th~ case of fast alpha particles in tissue. all 12C (a.:a:n)ii C reactions cease at 0.5 mm (0.02 in. ) from: the end of the track. Rosenthal 1959 and Anger 1963) . The positron camera uses an image detector and a focal detector aligned on opposite sides of the subject, along with coincidence circuitry and electronic coordinate computation techniques, to produce an image of the positron annihilations within a subject. The image is in the form of dots on a cathode-ray tube, and may be photographed to yield a picture of the activation pattern. On the basis of a further, experiment in which the alpha beam was completely stopped and the positron activity due to the (putatively) neutron background was observed alone. it was found that the background activity amountedto roughly 10% of the activity due to the charged particles. If one assumes that the (n.2n) cross section is approximately equal to the (a. an) cros s section in our situation, the conclusion is that the
total neutron intensity inddent on the phantom is roughly 10% of the alpha particle intensity. Most of these neutrons, however, are believed to be due to nuclear reactions in the brass collimator and copper absorber, and are not b~lieved to be associated with the cyclofron alpha beam itself.
DespIte these side effects, it is clear that this technique makes it possible to ~isualize and loc~te the end of the track ofa positivel~ In the next experimElI~t we attempted to discern the activation pattern resulting from the transmission of 910 MeV alpha beams in a situation similar to that of a patient irradiation. We used a paraffin head phantom irr~dic~.ted with 2000 rads in each of three ports, separ'ated by 1.3 lnches caudally and staggered by 1 cm in the A-P direction. The " ".
colli~ator aperture was 1 cm by 1 cm square, and the phantom was rotated 70° about only one axis trahsverse to the beam. University of Califorhia Medical Center, San Francisco, 1968).
Possible applications
We envision several possible applications of the technique of tis-.
. ' , sue activation with radiation beams. Perhaps the most natural application w~uld be the lire of the p~sitron ca~era as an ofi-line alignment tool for pati'ent therapy ~th the Bragg peak of positively charged heavy particle' beam's. (Se~, for ex~mple, Kjellberg, Swe~t, 1963, or Gottschalk, 1963) . Since alignment in the (x-y) plane transverse to the beam axis is alr'eady very good with conventional tnethods, the'important pa.rameter to be controlledis penetration of the beam along the beam axis (the "21" coordinate). In other words, because 'of variation of density and composition of tissue, bone, sinuses~ etc., it is difficult to predict exactly at what depth the Bragg peak will occur. Koehler, Dickinson, and Preston (1965) give a different solution to the problem.
U~ing the activation technique, however, it might be possible to visualize the end of the beam track (and, therefore, determine the Bragg peak depth) with the adminis tration of a few rads, and adjust the beam ene r gy so that the peak would coincide exactly with the volume to be irradiated (e. g. , tumour, pituitary,etc.). The rest of the treatment dose could then be completed. This method imposes three requirements on the acti~atiofi visualization system: 1) the activation ca:rp.era must be "on-line, "i. e. , with detectors iJ;l the treat_nent cave, and with fast readout; 2) the spatial resolution of the activation camera must be such that it could be used to alignthe beam end with sufficient accuracy (e. g., ± 3mm) in a small target; 3) the sensitivity of the activation camera must be such that it produces a usable picture with a small alignment dose (e~ g., 30 rads or les s).
The first requirement is not difficult: the only problem envisioned is that of sl1ielding the detectors or discriminating in some way against Table 1 ; the mean energy of the distribution is about 1/3 of the maximum; and, therefore, the mean range of the positroz:..s is less than 1/3 of the maximum.' The second faCtor is that the positrons are emitted isotropically in the three spatial dimensions:
x, y, z; if we let r equalthe radial penetration of the positron, r2=x 2 + y2+ z2, and by isotropy, z2 (mean) = 1/3 r2 (mean). Since dispersion in the x and y directions are unimportant when we are considering penetration in the z-direction, 'we are left with the conclusion that the root-meansquare pentration of the positron in the x-directiC?n before annihilation is given by z (rms) s:::I 0.58 r (mean). The net result is that a1 MeV (max) positron spectrum contributes less than 1 mm to the resolution of the image in the direction of the beam axis. This contribution is thus small compared with the contribution of the NaI crystal and phototube detection array (about 5 mm), but there are several possibilities of improving the inherent detector resolution (Anger 1966b ) .
In light of the fact that 760 rads in a patient's head produced a picture with 2320 dots in 8 minutes exposure after about 18 minutes delay from beam shut-off, one.might surmise that it would be impossible could"produce 300 dots per minute initially, and estimating that 600 dots can make a useful picture for z-direction alignment purposes, this could be 'accomplished with a 2 minut~ exposure. Thus, an "on-line" positron camera with slight improvement in sensitivity and a factor of 2 improvements in resolution could be a useful alignment and diagnostic tool for charged particle radiation therapy.
Other applications
A natural extension of the idea of visualising the activation due to heavy charged particle beams is the possibility of visualizing other beams.
Recently there has been much discussion of using other heavy particle beams for therapy, including pi mesons. neutrons, and very heavy ions.
for .reas,ons of higher LET, lower OER, and better depth-dose distribution.
It is likely that the (n. 2n) reactions occurring from neutron beams will leave a good amount of positron activity in tissue. Unquestionably, heavy ion beams will leave activity very similar to that of the alpha particle beams discus sed above. There·havebeen several other interesting suggestions for the use of tissue activation techniques (Sargent 1962 and Biomedical Studies. 1967) . If a microbearn of particles were incident on a part of an organism or a cell organeile (e. g., a' ~hloroplast),activation analysis techniques might be used to determi~e the location and amount of trace metals, etc.
In vivo activation analysis with charged particles might prove useful for quantitative determination of tissue constituents. Also, tracer studies with short-lived radionuclides might be expedited by generating the radionuclides within an organ of the body, using a particle beam, or even by implanting radioactive ions in the body.
ACKN,OWLEDGMENTS
We wish to thank Edward J. ter~tesuiting .from a910 MeV alpha particle beacl stopping in a tiJsue:'" like plastic phantom, at the Berkeley 184-inch synchrocyclotron. Also studied were the activation patterns resulting from transmission of 910
MeV alpha beams through a wax head phantom, and the activation pattern in patients I heads resulting from one sitting of the pituitary ablation therapy technique.
With slight improvements in resolution and sensitivity, an lIonline" positron camera technique could be useful for alignment of the end of the beamtrackin Bragg peak therapy with heavy charged particles.
There are other novel applications which might be possible, using tissue activation techniques. "- Minutes after irradiation .....
..... Alpha-particle energy MeV . This report was prepared a~ an account of Government sponsored work.
Neither the United States, nor the Comm1SS10n, nor any person acting on behalf of the Commission:
A.
Makes any warranty or representation, expressed or implied, with respect to the accuracy, completeness, or usefulness of the information contained in this report, or that the use of any information, apparatus, method, or process disclosed in this report may not infringe privately owned rights; or B.
Assumes any liabilities with respec~ to the use of, or for damages resulting from the use of any information, apparatus, method, or process disclosed in this report.
As used in the above, "person acting on behal f of the Commission" includes any employee or contractor of the Commission, or employee of such contractor, to the extent that such employee or contractor of the Commission, or employee of such contractor prepares, disseminates, or provides access to, any information pursuant to his employment or contract wi~h the Commission, or his employment with such contractor.
